Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00667160 · ClinicalTrials.gov registry record · Phase 4
Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Pediatric Patients With Mild Atopic Dermatitis
A Phase 4 study, sponsored by Astellas Pharma.
- Completed
- Registry status
- Phase 4
- Development phase
- 426
- Enrollment target
NCT00667160 is a Phase 4 study that has completed, run by Astellas Pharma. The registered enrollment target is 426 participants.
The verdict
NCT00667160, a Phase 4 study, has completed, sponsored by Astellas Pharma.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 426 participants
- Enrollment target
Study Summary
A study to compare the safety and efficacy of Protopic and Elidel in treating mild Atopic Dermatitis in pediatric patients
Interventions
- DRUG tacrolimus ointment
- DRUG pimecrolimus cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 426 participants |
| Start Date | 2002-12 |
| Est. Completion | 2003-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00667160
The ClinicalTrials.gov registry entry for NCT00667160 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 426 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Astellas Pharma, which has 165 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which tacrolimus ointment is the first listed.
NCT00667160 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00667160 about?
NCT00667160 is a clinical study titled "Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Pediatric Patients With Mild Atopic Dermatitis". A study to compare the safety and efficacy of Protopic and Elidel in treating mild Atopic Dermatitis in pediatric patients
What is the current status of trial NCT00667160?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 426 participants. The study started on 2002-12. Estimated completion is 2003-11.
What interventions are being tested in trial NCT00667160?
The interventions under investigation include: tacrolimus ointment (DRUG), pimecrolimus cream (DRUG).
Who is sponsoring clinical trial NCT00667160?
This trial is sponsored by Astellas Pharma, which has 165 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.